-
Jan 08, 2021 16:13 Source: BSE
Everest Organics - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
With reference to the captioned subject, we hereby inform you that the attached details of the share certificate is reported to have been lost by the shareholders of the Company. This is for your information and record
-
Jan 07, 2021 17:07 Source: BSE
Everest Organics - Temporary Closure Order
We hereby disclose the Temporary Closure Order issued by TSPCB.
-
Jan 05, 2021 15:34 Source: BSE
Everest Organics - Shareholding for the Period Ended December 31, 2020
Everest Organics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here
-
Jan 05, 2021 14:48 Source: BSE
Everest Organics - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to the provisions of Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018, please find enclosed a copy of the certificate for the quarter ended December 31, 2020 as received from M/s. Venture Capital and Corporate Investments Private Limited, the Registrar and Share Transfer Agent of the Company. This is for your information and records.
-
Jan 05, 2021 11:22 Source: BSE
Everest Organics - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter | No.of Investor complaints received during the quarter | No.of Investor complaints disposed of during the quarter | No.of Investor complaints unresolved at the end of the quarter |
---|
0 | 1 | 1 | 0 |
Name of the Signatory | :- | REKHA SINGH |
Designation | :- | Company Secretary and Compliance Officer |
-
Jan 01, 2021 10:06 Source: BSE
Everest Organics - Closure of Trading Window
This is to inform that as per the Company''s Internal Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons, the Trading Window for dealing in the securities of the Company shall remain closed for all designated persons including promoters, directors, key managerial personnel, employees, connected persons, insiders and their immediate relatives with effect from January 1, 2021 till 48 hours after the declaration of the Un-audited Financial Results of the Company for the quarter ended December 31, 2020. The date of Board Meeting of the Company for declaration of the financial results of the Company for the quarter ended on December 31, 2020 will be intimated in due course. This is for your information and records.
-
Dec 25, 2020 12:48 Source: BSE
Everest Organics - Disclosure Under Regulation 29 (2) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations, 2011 And Regulation 7 (2) Read With Regulation 6(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015
With reference to the captioned subject, please find enclosed herewith the disclosure received from the acquirer M/s. BK Advance Research, LLP, PAC of the Company in Form 29(2) under Regulation 29 of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011 and Form C under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015. Kindly take the above information on record.
-
Dec 25, 2020 12:42 Source: BSE
Everest Organics - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for BK Advance Research, LLP
-
Dec 24, 2020 16:03 Source: BSE
Everest Organics - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for BK Advance Research, LLP
-
Dec 24, 2020 13:08 Source: BSE
Everest Organics - Disclosure Under Regulation 29 (2) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations, 2011 And Regulation 7 (2) Read With Regulation 6(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015
With reference to the captioned subject, please find enclosed herewith the disclosure received from the acquirer M/s. BK Advance Research, LLP, PAC of the Company in Form 29(2) under Regulation 29 of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011 and Form C under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015. Kindly take the above information on record.